Adi Diab Selected Research

cyclopropapyrroloindole

1/2022	Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
1/2021	Infliximab for the treatment of patients with checkpoint inhibitor-associated acute tubular interstitial nephritis.
1/2019	Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.
10/2018	Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis.
10/2018	Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adi Diab Research Topics

Disease

56	Neoplasms (Cancer) 12/2022 - 05/2006
47	Melanoma (Melanoma, Malignant) 03/2022 - 05/2006
5	Brain Neoplasms (Brain Tumor) 04/2022 - 01/2017
5	Colitis 01/2022 - 10/2018
5	Disease Progression 12/2019 - 03/2016
4	Breast Neoplasms (Breast Cancer) 04/2022 - 10/2016
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 11/2019
3	Enterocolitis 01/2022 - 10/2018
3	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2019
3	Dermatitis 09/2019 - 02/2017
3	Diarrhea 12/2018 - 10/2018
3	Experimental Melanoma 11/2017 - 05/2006
2	Arthritis (Polyarthritis) 12/2022 - 12/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 09/2006
2	Headache (Headaches) 01/2021 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2020
2	Fatigue 01/2021 - 11/2019
2	Hypothyroidism 01/2021 - 10/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2021
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021 - 01/2019
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 01/2020
2	Leukemia 01/2020 - 01/2013
2	Infections 11/2018 - 09/2006
2	Bullous Pemphigoid (Pemphigoid) 10/2018 - 02/2017
2	Exanthema (Rash) 12/2017 - 12/2016
2	Grover's disease 01/2017 - 01/2016
1	Urologic Neoplasms (Urological Cancer) 10/2022
1	Carcinoma (Carcinomatosis) 10/2022
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022
1	Syncope (Fainting) 01/2022
1	Hypophysitis 01/2021
1	Uveal melanoma 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Nevus (Nevi) 10/2020

Drug/Important Bio-Agent (IBA)

33	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2016
13	NivolumabIBA 10/2022 - 10/2018
13	IpilimumabIBA 01/2022 - 01/2016
12	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2016
9	bempegaldesleukinIBA 10/2022 - 01/2019
7	pembrolizumabIBA 01/2022 - 01/2016
6	Interleukin-2 (IL2)IBA 10/2021 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 04/2022 - 05/2006
5	cyclopropapyrroloindoleIBA 01/2022 - 10/2018
5	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2019 - 12/2017
4	LigandsIBA 03/2022 - 03/2016
4	CTLA-4 AntigenIBA 01/2022 - 03/2016
4	CytokinesIBA 01/2021 - 12/2016
4	Infliximab (Remicade)FDA Link 01/2021 - 10/2018
4	SteroidsIBA 01/2019 - 10/2018
4	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 05/2006
3	Programmed Cell Death 1 ReceptorIBA 03/2022 - 10/2020
3	AntibodiesIBA 01/2021 - 03/2016
3	dabrafenibIBA 09/2019 - 08/2016
3	Neoplasm Antigens (Tumor Antigens)IBA 12/2016 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	InterferonsIBA 01/2021 - 10/2020
2	AntigensIBA 01/2021 - 09/2006
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2018
2	trametinibIBA 01/2018 - 08/2016
2	tocilizumab (atlizumab)FDA Link 12/2017 - 01/2016
2	Biological ProductsIBA 12/2017 - 09/2014
2	DNA VaccinesIBA 01/2013 - 09/2006
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	ProdrugsIBA 10/2022
1	Trastuzumab (Herceptin)FDA Link 04/2022
1	tremelimumabIBA 04/2022
1	Chemokine CXCL13IBA 01/2022
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2022
1	IntegrinsIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 01/2022
1	Integrin alpha4beta1 (VLA-4)IBA 01/2022
1	Dietary Fiber FDA Link 12/2021
1	Toll-Like Receptor 9IBA 01/2021
1	AM0010IBA 01/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021
1	atezolizumabIBA 01/2021
1	tilsotolimodIBA 01/2021
1	CreatinineIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	CateninsIBA 10/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2020

Therapy/Procedure

50	Therapeutics 12/2022 - 01/2013
22	Immunotherapy 03/2022 - 09/2014
5	Radiotherapy 04/2022 - 10/2018
2	Drug Therapy (Chemotherapy) 10/2022 - 10/2016
2	Liver Transplantation 03/2022 - 01/2019
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2018
2	Hematopoietic Stem Cell Transplantation 01/2021 - 09/2006
2	Organ Transplantation 06/2019 - 01/2019
2	Precision Medicine 01/2017 - 01/2016
2	Cryosurgery 12/2016 - 10/2016
2	Ligation 05/2010 - 05/2006
1	Immunomodulation 12/2022
1	Radiofrequency Ablation 03/2022
1	Transplantation 01/2021
1	Injections 01/2020